TrialFrontiers of medicine2016

Efficacy and safety of JAK inhibitor INC424 in patients with primary and post-polycythemia vera or post-essential thrombocythemia myelofibrosis in the Chinese population.

Xin Du et al.PubMed ↗Publisher ↗

No numbers read from the abstract.